World's Best Scientists 2026 revealed!
Bengt Glimelius

Bengt Glimelius

Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 144 1413 1306 30 29 1049 103195

Bengt Glimelius publications per year

The chart shows the history of publications by Bengt Glimelius between 1974 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Bengt Glimelius published across 52 years, from 1974 to 2025, averaging 21.4 papers a year. Output peaked at 57 publications in 2014. 41 of the 1,112 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 1974 to 2025. Vertical axis: number of publications, 0 to 57. Peak 57 publications in 2014. 1974: 1 publication 1975: 1 publication 1976: 0 publications 1977: 4 publications 1978: 5 publications 1979: 1 publication 1980: 0 publications 1981: 6 publications 1982: 4 publications 1983: 2 publications 1984: 4 publications 1985: 7 publications 1986: 4 publications 1987: 8 publications 1988: 16 publications 1989: 11 publications 1990: 12 publications 1991: 8 publications 1992: 12 publications 1993: 15 publications 1994: 24 publications 1995: 26 publications 1996: 23 publications 1997: 23 publications 1998: 25 publications 1999: 22 publications 2000: 17 publications 2001: 40 publications 2002: 44 publications 2003: 25 publications 2004: 22 publications 2005: 54 publications 2006: 24 publications 2007: 39 publications 2008: 35 publications 2009: 29 publications 2010: 33 publications 2011: 37 publications 2012: 40 publications 2013: 42 publications 2014: 57 publications 2015: 33 publications 2016: 31 publications 2017: 33 publications 2018: 38 publications 2019: 19 publications 2020: 31 publications 2021: 28 publications 2022: 18 publications 2023: 38 publications 2024: 23 publications 2025: 18 publications
1974 2025

1,112 publications in total across all disciplines

View publications per year as a table
Bengt Glimelius: publications per year, 1974 to 2025
Year Publications
1974 1
1975 1
1976 0
1977 4
1978 5
1979 1
1980 0
1981 6
1982 4
1983 2
1984 4
1985 7
1986 4
1987 8
1988 16
1989 11
1990 12
1991 8
1992 12
1993 15
1994 24
1995 26
1996 23
1997 23
1998 25
1999 22
2000 17
2001 40
2002 44
2003 25
2004 22
2005 54
2006 24
2007 39
2008 35
2009 29
2010 33
2011 37
2012 40
2013 42
2014 57
2015 33
2016 31
2017 33
2018 38
2019 19
2020 31
2021 28
2022 18
2023 38
2024 23
2025 18
Total 1,112
Download as CSV

Bengt Glimelius publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bengt Glimelius sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 1,041–1,060 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 1,049 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63 1,049
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Bengt Glimelius D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bengt Glimelius sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 144–145 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 144 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109 144
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Research.com Recognitions

  • 2023 - Research.com Medicine in Sweden Leader Award

Overview

Bengt Glimelius is a researcher affiliated with Uppsala University in Sweden, specializing in medicine with a focus on oncology and colorectal cancer. Their work encompasses various aspects of colorectal cancer treatments, surgical interventions, screening, and genetic factors, alongside broader interests in cancer genomics and diagnostics as well as gastric cancer management.

Their research portfolio includes numerous publications in prominent venues with a significant number appearing in the following journals:

  • Annals of Oncology
  • Cancers
  • Journal of Clinical Oncology
  • Radiotherapy and Oncology
  • UNC Libraries

Glimelius' recent influential papers demonstrate a concentration on rectal and colon cancer treatment methods. Selected recent publications include:

  • "Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial" (2020) published in The Lancet Oncology
  • "Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial" (2023) in Journal of Clinical Oncology
  • "Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery" (2023) in Annals of Surgery
  • "Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial" (2020) in Radiotherapy and Oncology
  • "Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study" (2023) in Cancer Cell

The scientist frequently collaborates with several co-authors who have contributed alongside in numerous publications. These include:

  • Tobias Sjöblom
  • Per J. Nilsson
  • Per Pfeiffer
  • Pia Österlund
  • Corrie A.M. Marijnen

In terms of academic fields, the main area of study is medicine, with a more refined focus on:

  • Oncology
  • Surgery
  • Pathology and Forensic Medicine
  • Pulmonary and Respiratory Medicine
  • Cancer Research

The dominant topics covered in Bengt Glimelius's research include colorectal cancer treatments and studies, colorectal cancer surgical treatments, colorectal and anal carcinomas, colorectal cancer screening and detection, genetic factors in colorectal cancer, gastric cancer management and outcomes, and cancer genomics and diagnostics.

Best Publications

  • Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer

    Ellen Kapiteijn;Corrie A.M. Marijnen;Iris D. Nagtegaal;Hein Putter

  • A pathology atlas of the human cancer transcriptome

    Mathias Uhlen;Mathias Uhlen;Cheng Zhang;Sunjae Lee;Evelina Sjöstedt;Evelina Sjöstedt

  • Improved survival with preoperative radiotherapy in resectable rectal cancer.

    B Cedermark;M Dahlberg;B Glimelius

  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Bengt Glimelius;Graeme J Poston

  • Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

    John P. Neoptolemos;John P. Neoptolemos;Daniel H. Palmer;Daniel H. Palmer;Paula Ghaneh;Eftychia E. Psarelli

  • Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

    Willem van Gijn;Carrie A. M. Marijnen;Iris D. Nagtegaal;Elma Meershoek-Klein Kranenbarg

  • ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    H J Schmoll;E Van Cutsem;A Stein;V Valentini

  • Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Bengt Glimelius;Lars Påhlman;A. Cervantes

  • Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983) : long-term results of a randomised, controlled, phase 3 trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

  • The TME Trial After a Median Follow-Up of 6 Years: Increased Local Control but No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma

    Koen C. M. J. Peeters;Corrie A. M. Marijnen;Iris D. Nagtegaal;Elma Klein Kranenbarg

  • Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer

    B Glimelius;K Ekström;K Hoffman;W Graf

  • Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib the LAP07 randomized clinical trial

    Pascal Hammel;Florence Huguet;Jean-Luc van Laethem;David Goldstein

  • Swedish rectal cancer trial : Long lasting benefits from radiotherapy on survival and local recurrence rate

    Joakim Folkesson;Helgi Birgisson;Lars Pahlman;Bjorn Cedermark

  • Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

    B Glimelius;Katarina Hoffman;P-O Sjoden;G Jacobsson

  • Sexually Transmitted Infection as a Cause of Anal Cancer

    Frisch M;Glimelius B;van den Brule Aj;Wohlfahrt J

  • Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial.

    Lars Påhlman;Bengt Glimelius

  • Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

    Richard Herrmann;György Bodoky;Thomas Ruhstaller;Bengt Glimelius

  • DUTCH COLORECTAL CANCER GROUP. PREOPERATIVE RADIOTHERAPY COMBINED WITH TOTAL MESORECTAL EXCISION FOR RESECTABLE RECTAL CANCER

    E Kapiteijn;C A Marijnen;I D Nagtegaal;H Putter

  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983)

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

Frequent Co-Authors

Lars Påhlman
Lars Påhlman Uppsala University
Hans-Olov Adami
Hans-Olov Adami Karolinska Institute
Mads Melbye
Mads Melbye University of Copenhagen
Peter Nygren
Peter Nygren Uppsala University
Karin E. Smedby
Karin E. Smedby Karolinska University Hospital
Henrik Hjalgrim
Henrik Hjalgrim Statens Serum Institut
Christer Sundström
Christer Sundström Uppsala University
David Cunningham
David Cunningham Royal Marsden NHS Foundation Trust
Ellen T. Chang
Ellen T. Chang Stanford University
Angela Brooks-Wilson
Angela Brooks-Wilson Simon Fraser University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean medical school. There are several respected online degrees that open doors within the healthcare field. These programs are ideal for those who want to play a critical role in healthcare while balancing studies with work or family commitments.

If you’re interested in leadership roles, consider a healthcare administration degree online. This program teaches management, policy, and organizational skills. For advanced positions, you might research the most affordable online mha programs, which offer specialized expertise at the graduate level.

Nursing professionals wanting to impact patient care can look into cheap dnp online programs. A Doctor of Nursing Practice prepares you for leadership or clinical roles with a flexible online format. Pharmacists can boost their qualifications through an online pharmd degree, tailored for career advancement or specialized practice.

These pathways provide affordable and flexible alternatives to traditional on-campus degrees, supporting a variety of rewarding healthcare careers beyond medicine itself.

Best Scientists Citing Bengt Glimelius

Trending Scientists

Recently Published Articles